pharmazz

Diabetic Ketoacidosis

  • Gulati, A., Lavhale, M., Marwah, B., Khandelwal, S., and Havalad, S. (2014) ETA receptor antagonist, BQ123, in the treatment of Diabetic Ketoacidosis. Basic Clin Pharmacol 115, 240-240
  • Havalad, V., Gulati, A., Swanson, E., Briyal, S., Ghai, K., Heneghan, M.K., Havalad, S. (2013) Diabetic children with DKA have elevated Endothelin-1 levels. Pediatric Academic Societies EPAS2013:2910.100
  • Gulati, A., Lavhale, M., and Havalad, S. (2013) BQ123, An ETA receptor antagonist, in the treatment of Diabetic Ketoacidosis. Crit Care Med 41
    Read more
  • Gulati, A., Lavhale, M., Marwah, B., and Havalad, S. (2013) ETA receptor antagonists in the treatment of diabetic ketoacidosis. Life Sciences 93, e73
    Read more
  • Gulati, A., Lavhale, M. S., Koenig, K., and Havalad, S. (2009) ET receptor antagonist in the treatment of Diabetic Ketoacidosis. J Clin Pharmacol 49, 1125